Opportunity
Simpler Grants.gov #NOT-DK-26-307
NIH Pre-Solicitation: Research Funding for AI/ML-Driven Diabetes Control Technologies
Buyer
National Institute of Diabetes and Digestive and Kidney Diseases
Posted
June 18, 2025
Respond By
October 01, 2025
Identifier
NOT-DK-26-307
NAICS
541715, 541714
The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is announcing an upcoming funding opportunity for research on advanced diabetes control technologies: - Government Buyer: - National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Focus Areas: - Development of open- and closed-loop diabetes control systems - Innovation in sensing analytes and physiologic signals - Novel hormone formulation and delivery methods - Artificial intelligence (AI) and machine learning (ML) tools and algorithms - Digital twin modeling for decision support and automated control - Objective: - Improve glycemic control, reduce care burden, and enhance quality of life for individuals with Type 1 Diabetes (T1D) - Eligibility: - Open to nonprofit, educational, governmental, business, and other organizations - Notable Requirements: - Emphasis on AI/ML-driven solutions and digital twin modeling - No specific OEMs, vendors, or products identified (research grant opportunity) - Notice is for planning and collaboration; applications not yet solicited
Description
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to publish a Notice of Funding Opportunity (NOFO) to solicit research applications aimed at overcoming barriers to more effective open- and closed-loop diabetes control systems. Research areas include innovation in sensing analytes and physiologic signals, novel hormone formulation and delivery, AI/ML-driven tools and algorithms, and digital twin modeling to support decision-making and automated control. The goals are to improve glycemic control, reduce the burden of care, and enhance quality of life for people with Type 1 Diabetes (T1D). This notice provides potential applicants time to develop collaborations and projects, as applications are not currently being solicited.